SKI Market

A+| A| A-|

Indian Indices

Sensex

76,704.13 633.29
( 0.83%)

Global Indices

Nasdaq

47,030.54 63.12
(0.13%)

Dow Jones

6,739.22 18.84
(0.28%)

Hang Seng

55,100.12 1,399.73
(2.61%)

Nikkei 225

10,406.71 89.02
(0.86%)

Forex

USD-INR

92.33 0.01
(0.01%)

EUR-INR

105.92 0.52
(0.49%)

GBP-INR

122.63 0.58
(0.47%)

JPY-INR

0.58 0.00
(0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

JFL Life Sciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

535469

INE0LA901015

11.3920003

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JFLLIFE

13.22

63.68

EPS(TTM)

Face Value()

Div & Yield %

0.73

Back

Abhinav Leasing & Finance standalone net profit rises 616.67% in the September 2025 quarter

Nov 15,2025

Net profit of Abhinav Leasing & Finance rose 616.67% to Rs 0.43 crore in the quarter ended September 2025 as against Rs 0.06 crore during the previous quarter ended September 2024. Sales declined 65.15% to Rs 3.06 crore in the quarter ended September 2025 as against Rs 8.78 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3.06	8.78	-65
OPM %	14.71	27.11	-
PBDT	0.44	0.07	529
PBT	0.43	0.06	617
NP	0.43	0.06	617

76,704.13 633.29 ( 0.83%)

47,030.54 63.12 (0.13%)

6,739.22 18.84 (0.28%)

55,100.12 1,399.73 (2.61%)

10,406.71 89.02 (0.86%)

92.33 0.01 (0.01%)

105.92 0.52 (0.49%)

122.63 0.58 (0.47%)

0.58 0.00 (0.31%)